Background: Glioblastoma (GBM) is a high-grade intracranial malignancy with a propensity to progress. We analyzed the National Cancer Database (NCDB) to examine trends in the use of stereotactic radiosurgery (SRS).
Conclusion: Utilization of SRS in the management of GBM has decreased over time, likely reflecting penetrance of multiple prospective and retrospective studies demonstrating no survival benefit. Concordant with previous findings, overall survival was not improved with SRS in our investigation.
